Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

164.29
BATS BZX Real-Time Price
As of 2:47pm ET
 +1.23 / +0.75%
Today’s Change
133.64
Today|||52-Week Range
184.21
+12.37%
Year-to-Date
Amgen's Leukemia Drug Accepted for Priority Review by FDA
10:17am / Zacks.com - Paid Partner Content
J&J (JNJ) Anaemia Drug Marketing Label Expanded in Europe
Mar 27 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Regeneron, Tesaro Drugs Approved, Vertex Scores Big in Study
Mar 29 / Zacks.com - Paid Partner Content
Merck's Ketruda Gets Positive CHMP Opinion for Lymphoma
Mar 27 / Zacks.com - Paid Partner Content
Pfizer's Arthritis Drug Xeljanz Gets Marketing Nod in Europe
Mar 28 / Zacks.com - Paid Partner Content
6 Best Stocks for Value Investors This Week
Mar 26 / GuruFocus News - Paid Partner Content
The 'Fearless Girl' Statue Isn't a Symbol, It Is an Advertisement
Mar 27 / Zacks.com - Paid Partner Content
Amgen's (AMGN) Humira Biosimilar Receives Approval in EU
Mar 24 / Zacks.com - Paid Partner Content
Amgen's Humira Biosimilar Approved in Europe
Mar 27 / GuruFocus News - Paid Partner Content
Pfizer's Immunotherapy for Skin Cancer Gets FDA Approval
Mar 24 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close163.06
Today’s open164.26
Day’s range163.24 - 164.79
Volume111,787
Average volume (3 months)3,870,564
Market cap$120.1B
Dividend yield2.80%
Data as of 2:47pm ET, 03/30/2017

Growth & Valuation

Earnings growth (last year)+13.02%
Earnings growth (this year)+6.28%
Earnings growth (next 5 years)+6.55%
Revenue growth (last year)+6.31%
P/E ratio16.1
Price/Sales4.86
Price/Book4.03

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.40+0.59%
BIIBBiogen+1.09+0.41%
ILMNIllumina Inc+1.20+0.70%
BIVVBioverativ Inc-0.99-1.86%
Data as of 2:47pm ET, 03/30/2017

Financials

Next reporting dateApril 26, 2017
EPS forecast (this quarter)$3.00
Annual revenue (last year)$22.7B
Annual profit (last year)$7.7B
Net profit margin34.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts


Search for Jobs